A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer
Clinical trial NCT06685796 · COMPLETED
Trial details
- NCT number
- NCT06685796
- Sponsor
- BeBetter Med Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-12
- Primary completion
- 2026-04-20
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.